Kalinor-Retard P en es it fr

Kalinor-Retard P Brand names, Kalinor-Retard P Analogs

Kalinor-Retard P Brand Names Mixture

  • No information avaliable

Kalinor-Retard P Chemical_Formula

C10H20O

Kalinor-Retard P RX_link

No information avaliable

Kalinor-Retard P fda sheet

Kalinor-Retard P msds (material safety sheet)

Kalinor-Retard_P MSDS

Kalinor-Retard P Synthesis Reference

No information avaliable

Kalinor-Retard P Molecular Weight

156.265 g/mol

Kalinor-Retard P Melting Point

43 oC

Kalinor-Retard P H2O Solubility

0.49 mg/mL at 25 oC [CHEM INSPECT TEST INST (1992)]

Kalinor-Retard P State

Solid

Kalinor-Retard P LogP

3.211

Kalinor-Retard P Dosage Forms

Cream; Drops; Gel; Globules; Jelly; Liquid; Lozenge; Ointment; Patch; Powder; Spray; Stick

Kalinor-Retard P Indication

Used to treat occasional minor irritation, pain, sore mouth, and sore throat as well as cough associated with a cold or inhaled irritants.

Kalinor-Retard P Pharmacology

Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. Menthol's ability to chemically trigger cold-sensitive receptors in the skin is responsible for the well known cooling sensation that it provokes when inhalated, eaten, or applied to the skin. It should be noted that menthol does not cause an actual drop in temperature.

Kalinor-Retard P Absorption

No information avaliable

Kalinor-Retard P side effects and Toxicity

Menthol, DL: ORAL (LD50): Acute: 2900 mg/kg [Rat], 3100 mg/kg [Mouse]. DERMAL (LD50): Acute: 5001 mg/kg [Rabbit].

Kalinor-Retard P Patient Information

Kalinor-Retard P Organisms Affected

Humans and other mammals